Wave Life Sciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, will be participating at the following conferences:

About Wave Life Sciences

Wave Life Sciences is a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases. Our chemistry platform enables the creation of highly specific, well characterized oligonucleotides designed to deliver superior efficacy and safety across multiple therapeutic modalities. Our pipeline is initially focused on neurological disorders and extends across several other therapeutic areas. For more information, please visit www.wavelifesciences.com.

Investor Contact:

Jillian Connell
617-949-2981
[email protected]

Media Contact:

Jose Juves
617-949-4708
[email protected]

You May Also Be Interested In

• Information regarding executed transactions within the framework of a share buyback programme (outside the liquidity agreement) from 24 August to 28 August 2026
• Amber Premium Transforms into AMBR, Dedicated to Building Specialized AI Agents for Finance, Enterprise, and Growth
• CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES